Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
Public ClinicalTrials.gov record NCT00558038. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparison of Different Treatment Regimens in Patients With Stage 1-2 Type C Hepatic Encephalopathy: AST-120 vs Lactulose
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and effectiveness of the experimental drug AST-120 compared to lactulose in patients with mild hepatic encephalopathy.
Study identification
- NCT ID
- NCT00558038
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Jun 2009 (Actual)
- Last update posted
- May 30, 2014
2007 – 2009
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| Scripps Clinic | San Diego | California | 92037 | — |
| Veterans Medical Center San Diego | San Diego | California | 92161 | — |
| Washington Hospital Center - MedStar Research Institute | Washington D.C. | District of Columbia | 20010 | — |
| Digestive Healthcare of Georgia | Atlanta | Georgia | 30309 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Tulane University Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| University of Massachusetts Medical School | Worchester | Massachusetts | 01655 | — |
| Weill Medical College of Cornell | New York | New York | 10021 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| Baylor University Medical Center | Houston | Texas | 77030 | — |
| St. Luke's Advanced Liver Therapies / St. Luke's Texas Liver Coalition - Baylor College of Medicine | Houston | Texas | 77030 | — |
| Metropolitan Research | Fairfax | Virginia | 22031 | — |
| McGuire VA Medical Center | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00558038, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2014 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00558038 live on ClinicalTrials.gov.